4Williams DO,Houlubkov R,Yeh W,et al.Precutaneous coronary intervention in the current era.Compared with 1985-1986:The National Heart,Lung,and Blood Institute Registries[J].Circulation,2000,102:2945.
5Mehilli J,Kastrti A,Dirschinger J,et al.Differences inprognostic factors and outcomes between women and men undergoing coronary artery stentiono[J].JAMA,2000,284:1799.
二级参考文献9
1Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol,2004,43: 1110-1115.
2Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAX-US-IV trial. Circulation, 2004, 109:1942-1947.
3Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coil Cardiol, 2001,37 : 2215-2239.
4Arampatzis CA, Hoye A, Lemos PA, et al. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis : one-year clinical outcomes of 99 consecutive patients-the Rotterdam experience. Catheter Cardiovasc Interv, 2004,63:57-60.
5Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Ennl J Med, 2003.349 : 1315-1323.
6Tanabe K, Serruys PW, Grube E, et al. TAXUS Ⅲ Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation, 2003,107:559-564.
7Kong DF, Eisenstein EL, Sketch MH Jr, et al. Economic impact of drug-eluting stents on hospital systems: a disease-state model. Am Heart J, 2004,147 : 449-456.
8Gulizia M, Martelli E, Tamburino C, et al. Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents. Ital Heart J Suppl, 2004,5: 630-638.
3Elsa Abitbol,Jean-Luc Monin,Jér?me Garot,Mehrane Monchi,Stéphanie Russel,Anne-Marie Duval,Pascal Gueret.Relationship between the ischemic threshold at the onset of wall-motion abnormality on semisupine exercise echocardiography and the extent of coronary artery disease[J].Journal of the American Society of Echocardiography.2003(2)
